Serum antibodies to Pseudomonas aeruginosa in cystic fibrosis as a diagnostic tool: A systematic review

Journal of Cystic Fibrosis

Volumn 13, Issue 5, 2014, Pages 499-507

  Mauch, Renan Marrichi ^a   Levy, Carlos Emilio ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Cystic fibrosis; Pseudomonas aeruginosa; Review; Serum antibodies

Indexed keywords

BACTERIUM ANTIBODY;

ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ANTIBODY TITER; CYSTIC FIBROSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; MULTICENTER STUDY (TOPIC); PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; REVIEW; SYSTEMATIC REVIEW; BLOOD; IMMUNOLOGY; PSEUDOMONAS INFECTIONS;

ANTIBODIES, BACTERIAL; CYSTIC FIBROSIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS;

EID: 84926081492     PISSN: 15691993     EISSN: 18735010     Source Type: Journal    
DOI: 10.1016/j.jcf.2014.01.005     Document Type: Review

References (45)

1. Kiska D.L., Riddell S.W. Practical laboratory aspects of cystic fibrosis microbiology: an update, part I. Clin Microbiol Newsl 2012, 34(4):27-31.
2. Gilligan P.H., Kiska D.L., Appleman M.D. Cystic fibrosis microbiology. Cumulative techniques and procedures in clinical microbiology 2006, 1-36. ASM Press, Washington, DC. M.D. Appleman (Ed.).
3. Brennan A.L., Geddes D.M. Cystic fibrosis. Curr Opin Infect Dis 2002, 15:175-182.
4. Lee T.W.R., Brownlee K.G., Conway S.P., Denton M., Littlewood J.M. Evaluation of a definition for chronic Pseudomonas aeruginosa infection in cystic fibrosis patients. J Cyst Fibros 2003, 2(1):29-34.
5. Döring G. Prevention of Pseudomonas aeruginosa infection in cystic fibrosis patients. IJMM 2010, 300:573-577.
6. Hauser A., Jain M., Bar-Meir M. Clinical significance of microbial infection and adaptation in cystic fibrosis. Clin Microbiol Rev 2011, 24(1):29-70.
7. Rosenfeld M., Emerson J., Accurso F., Armstrong D., Castile R., Grinwood K., et al. Diagnostic accuracy of oropharyngeal cultures in infants and young children with cystic fibrosis. Pediatr Pulmonol 1999, 28:321-328.
8. Tramper-Standers G.A., van der Ent C.K., Wolfs T.F.W. Detection of Pseudomonas aeruginosa in patients with cystic fibrosis. J Cyst Fibros 2005, 4:37-43.
9. Da Silva Filho L.V.F., Ferreira F.A., Reis F.J.C., Britto M.C.A.M., Levy C.E., Clark O., et al. Pseudomonas aeruginosa infection in patients with cystic fibrosis: scientific evidence regarding clinical impact, diagnosis and treatment. J Bras Pneumol 2013, 39(4):495-512.
10. Döring G., Taccetti G., Campana S., Festini F., Mascherini M. Eradication of Pseudomonas aeruginosa in cystic fibrosis patients. Eur Respir J 2005, 27(3):653.
11. Ratjen F., Doring G., Nikolaizik W.H. Effect of inhaled tobramycin on early Pseudomonas aeruginosa colonisation in patients with cystic fibrosis. Lancet 2001, 358:983-984.
12. Høiby N., Flensborg E.W., Beck B., Friis B., Jacobsen S.V., Jacobsen L. Pseudomonas aeruginosa in cystic fibrosis. Diagnostic and prognostic significance of Pseudomonas aeruginosa precipitins determined by means of crossed immunoelectrophoresis. Scand J Respir Dis 1977, 58:65-79.
13. Doring G., Høiby N. Longitudinal study of immune response to P. aeruginosa antigens in cystic fibrosis. Infect Immun 1983, 42:197-201.
14. Brett M.M., Ghoneim A.T.M., Littlewood J.M. Serum antibodies to Pseudomonas aeruginosa in cystic fibrosis. Arch Dis Child 1986, 61:1114-1120.
15. Hollsing A.E., Granström M., Vasil M.L., Wretlind B. Prospective study of serum antibodies to Pseudomonas aeruginosa exoproteins in cystic fbrosis. J Clin Microbiol 1987, 25:1868-1874.
16. Pedersen S., Espersen F., Høiby N. Diagnosis for chronic Pseudomonas aeruginosa infection in cystic fibrosis by enzyme-linked immunosorbent assay. J Clin Microbiol 1987, 25(10):1830-1836.
17. Brett M.M., Ghoneim A.T.M., Littlewood J.M. Prediction and diagnosis of early infection in cystic fibrosis: a follow-up study. J Clin Microbiol 1988, 26:1565-1570.
18. Formsgaard A., Høiby N., Shand G.H., Conrad R.S., Galanos C. Longitudinal study of antibody response to lipopolysaccharides during chronic Pseudomonas aeruginosa lung infection in cystic fibrosis. Infect Immun 1988, 56(9):2270-2278.
19. Kronborg G., Formsgaard A., Galanos C., Freudenberg M.A., Høiby N. Antibody response to lipid A, core, and O sugars of the Pseudomonas aeruginosa lipopolysaccharide in chronically infected cystic fibrosis patients. J Clin Microbiol 1992, 30(7):1848-1855.
20. Burns J.L., Gibson R.L., McNamara S., Yin D., Emerson J., Rosenfeld M., et al. Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis. J Infect Dis 2001, 183:444-452.
21. Moss J., Ehrmantraut M.E., Banwart B.D., Frank D.W., Barbieri J.T. Sera from adult patients with cystic fibrosis contains antibodies to Pseudomonas aeruginosa type III apparatus. Infect Immun 2001, 69:1185-1188.
22. West S.E., Zeng L., Lee B.L., Kosorok M.R., Laxova A., Rock M.J., et al. Respiratory infections with Pseudomonas aeruginosa in children with cystic fibrosis: early detection by serology and assessment of risk factors. JAMA 2002, 287:2958-2967.
23. Johansen H.K., Norregaard L., Gotzsche P.C., Pressler T., Koch C., Høiby N. Antibody response to Pseudomonas aeruginosa in cystic fibrosis patients: a marker of therapeutic success? A 30-year cohort study of survival in Danish of patients after onset of chronic Pseudomonas aeruginosa lung infection. Pediatr Pulmonol 2004, 37:427-432.
24. Corech R., Rao A., Laxova A., Moss J., Rock M.J., Li Z., et al. Early immune response to the components of the type III system of Pseudomonas aeruginosa in children with cystic fibrosis. J Clin Microbiol 2005, 43:3956-3962.
25. Kappler M., Kraxner A., Reinhardt D., Ganster B., Griese M., Lang T. Diagnostic and prognostic value of serum antibodies against Pseudomonas aeruginosa in cystic fibrosis. Thorax 2006, 61:684-688.
26. Tramper-Stranders G.A., van der Ent C.K., Slieker M.G., Terheggen-Lagro S.W., van Berkhout F.T., Kimpen J.L., et al. Diagnostic value of serological test against Pseudomonas aeruginosa in a large cystic fibrosis population. Thorax 2006, 61:689-693.
27. Pressler T., Frederiksen B., Skov M., Garred P., Koch C., Høiby N. Early rise of anti-Pseudomonasantibodies and a mucoid phenotype of Pseudomonas aeruginosa are risk factors for development of chronic lung infection - a case control study. J Cyst Fibros 2006, 5:9-15.
28. Weisner A.M., Chart H., Bush A., Davies J.C., Pitt T.L. Detection of antibodies to Pseudomonas aeruginosa in serum and oral fluid from patients with cystic fibrosis. J Med Microbiol 2007, 56:670-674.
29. Ratjen F., Walter H., Haug M., Meinser M.C., Grasemann H., Döring G. Diagnostic value of serum antibodies in early Pseudomonas aeruginosa infection in cystic fibrosis patients. Pediatr Pulmonol 2007, 42:349-355.
30. da Silva Filho L.V., Tateno A.F., Martins K.M., Azzuz Chernishev A.C., Garcia D.O., Haug M., et al. The combination of PCR and serology increases the diagnosis of Pseudomonas aeruginosa colonization/infection in cystic fibrosis. Pediatr Pulmonol 2007, 42(10):938-944.
31. Milagres L.G., Castro T.L., Garcia D., Cruz A.C., Higa L., Folescu T., et al. Antibody response to Pseudomonas aeruginosa in children with cystic fibrosis. Pediatr Pulmonol 2009, 44(4):392-401.
32. Pressler T., Karpati F., Granstrom M., Knudsen P.K., Lindbald A., Hjelte L., et al. Scandinavian CF Study Consortium. Diagnostic significance of measurements of specific IgG antibodies to Pseudomonas aeruginosa by three different serological methods. J Cyst Fibros 2009, (8):37-42.
33. Hayes D., Farrell P.M., Li Z., West S.E. Pseudomonas aeruginosaserological analysis in young children with cystic fibrosis diagnosed through newborn screening. Pediatr Pulmonol 2010, 45(1):55-61.
34. Douglas T.A., Brennan S., Berry L., Winfield K., Wainwright C.E., Grinwood K., et al. Value of serology in predicting Pseudomonas aeruginosa infection in young children with cystic fibrosis. Thorax 2010, 65(11):985-990.
35. Anstead M., Heltshe S., Khan U., Barbieri J.T., Langkramp M., Döring G., et al. Pseudomonas aeruginosa serology and risk for re-isolation in the EPIC trial. J Cyst Fibros 2012, 12(2):147-153.
36. Cruz A.C., Neves B.C., Higa L.Y.S. Type III apparatus of Pseudomonas aeruginosa as a tool to diagnose pulmonary infection in cystic fibrosis patients. APMIS 2012, 120:622-627.
37. Doğru D., Peckan S., Yalçin E., Ozçelik U., Kiper N., Gürcan N., et al. The role of serum Pseudomonas aeruginosa antibodies in the diagnosis and follow-up of cystic fibrosis. TJP 2013, 55:50-57.
38. Li Z., Kosorok M.R., Farell P.M., Laxova A., West S.E., Green C.G., et al. Longitudinal development of mucoid Pseudomonas aeruginosa infection and lung disease progression in children with cystic fibrosis. JAMA 2005, 293:581-588.
39. Milagres L., Garcia D., Castro T., Tavares K., Leão R., Folescu T., et al. Infecção pulmonar por Pseudomonas aeruginosa na fibrose cistica: diagnóstico sorológico e conduta. Pediatria (Sao Paulo) 2009, 30(1):56-65.
40. Jimenez P.N., Koch G., Thompson J.A., Xavier K.B., Cool R.H., Quax W.J. The multiple signaling systems regulating virulence in Pseudomonas aeruginosa. MMBR 2012, 76(1):46-65.
41. Winnie G.B., Cowan R.G. Respiratory tract colonization with Pseudomonas aeruginosa in cystic fibrosis: correlations between anti-Pseudomonas aeruginosa antibody levels and pulmonary function. Pediatr Pulmonol 1991, 10:92-100.
42. Tramper-Standers G.A., van der Ent C.K., Molin S., Yang L., Hansen S.K., Rau M.H., et al. Initial Pseudomonas aeruginosa infection in patients with cystic fibrosis: characteristics of eradicated and persistent isolates. Clin Microbiol Infect 2012, 18:567-574.
43. Farrel P.M., Govan J.R.W. Pseudomonas serology: confusion, controversy, and challenges. Thorax 2006, 61:645-647.
44. Proesmans M., Balinska-Mizkiewicz W., Dupont L., Bossuyt X., Verhaegen J., Høiby N., et al. Evaluating the "Leeds criteria" for Pseudomonas aeruginosa infection in a cystic fibrosis centre. Eur Respir J 2006, 27:937-943.
45. Pressler T., Bohmova C., Conway S., Dumcius S., Hjelte L., Høiby N., et al. Chronic Pseudomonas aeruginosainfection definition: EuroCareCF Working Group report. J Cyst Fibros 2011, 10(2):S75-S78.